CPHPC(Miridesap)
产品编号: DC10506
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Miridesap 是血清淀粉样蛋白 P 组分 (SAP) 的配体，能抑制和解离 SAP 与淀粉状蛋白原纤维的结合。
| Cas No.: |
224624-80-0 |
| 名称: |
|
| 别名: |
Miridesap； Ro-638695； Ro 638695； Ro638695；CPHPC；CPOHPC （acid form; CPOHPC acid |
| SMILES: |
O=C(N1[C@H](CCC1)C(O)=O)CCCCC(N2[C@H](CCC2)C(O)=O)=O |
| 分子式: |
C16H24N2O6 |
| 分子量: |
340.4 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Miridesap (also known as Ro-638695, GSK-2315698, and CPHPC) is an antineoplastic which depletes circulating serum amyloid P component (SAP) almost completely but leaves some SAP in amyloid deposits for specific recognition by subsequently administered therapeutic anti-SAP antibodies. Since Miridesap removes SAP from the blood, it also removes SAP from the cerebrospinal fluid (CSF). |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
| TITLE |
DOWNLOAD |
| MSDS_275_DC10506_224624-80-0 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
询盘
